Population Differences in Breast Cancer: Survey in Indigenous African Women Reveals Over-Representation of Triple-Negative Breast CancerDEZHENG HUO; IKPATT, Francis; MALAKA, David et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4515-4521, issn 0732-183X, 7 p.Article

Estrogen receptor a, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancersMINJIE WEI; JINHUA XU; DIGNAM, James et al.Breast cancer research and treatment. 2008, Vol 111, Num 1, pp 113-120, issn 0167-6806, 8 p.Article

BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomyMINJIE WEI; GRUSHKO, Tatyana A; OLOPADE, Olufunmilayo I et al.Cancer research (Baltimore). 2005, Vol 65, Num 23, pp 10692-10699, issn 0008-5472, 8 p.Article

MYC is amplified in BRCA1-associated breast cancersGRUSHKO, Tatyana A; DIGNAM, James J; SVEEN, Lise et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 499-507, issn 1078-0432, 9 p.Article

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neckPEREZ, Cesar A; HUNHO SONG; VOKES, Everett E et al.Oral oncology (1997). 2012, Vol 48, Num 9, pp 887-892, issn 1368-8375, 6 p.Article

Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck CancerCOHEN, Ezra E. W; HARAF, Daniel J; WITT, Mary Ellyn et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3336-3343, issn 0732-183X, 8 p.Article